Noxopharm Limited 36 Note 12. Equity - issued capital Consolidated 2022 2021 2022 2021 Shares Shares $ $ Ordinary shares - fully paid 292,237,950 288,221,727 74,635,721 72,622,560 Movements in ordinary share capital Details Date Shares $ Balance 1 July 2020 213,200,580 41,631,007 Conversion of collateral shares 22 July 2020 - 267,637 Conversion of options 14 August 2020 40,000 12,000 Conversion of options 9 October 2020 976 293 Conversion of options 26 October 2020 784 235 Conversion of options 18 November 2020 650,000 339,107 Conversion of options 1 December 2020 5,456 1,637 Capital raise (net of fees) 1 December 2020 42,592,592 16,360,077 Conversion of options 15 December 2020 448 134 Conversion of options 22 January 2021 1,789,612 536,884 Conversion of options 3 February 2021 2,623,265 786,980 Conversion of options 5 February 2021 1,917,073 578,860 Conversion of options 15 February 2021 729,705 218,912 Conversion of options 19 February 2021 2,942,061 889,913 Conversion of options 26 February 2021 8,267,133 2,480,140 Conversion of options 4 March 2021 4,112,664 1,233,799 Conversion of options 12 April 2021 4,215 1,265 Conversion of options 30 April 2021 2,963 889 Conversion of options 7 May 2021 1,333 400 Conversion of loan 31 May 2021 9,250,867 7,255,391 Conversion of options 21 June 2021 90,000 27,000 Balance 30 June 2021 288,221,727 72,622,560 Conversion of options 13 August 2021 6,667 2,000 Conversion of options 23 August 2021 48,101 14,430 Conversion of options 29 September 2022 3,961,455 1,996,731 Balance 30 June 2022 292,237,950 74,635,721
RkJQdWJsaXNoZXIy MjE2NDg3